# Anne-Els van de Logt

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anne-els-van-de-logt/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,298 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 16 |
| i10-index | 17 |
| Last Known Institution | Radboud University Nijmegen |
| OpenAlex ID | https://openalex.org/A5082862523 |
| Works | 53 |

## Researcher papers

- [The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy](https://scholariq.org/papers/the-starmen-trial-indicates-that-alternating-treatment-with-corticosteroids-and/)
- [The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery](https://scholariq.org/papers/the-anti-pla2r-antibody-in-membranous-nephropathy-what-we-know-and-what-remains/)
- [Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy](https://scholariq.org/papers/novel-elisa-for-thrombospondin-type-1-domain-containing-7a-autoantibodies-in/)
- [Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab](https://scholariq.org/papers/immunological-remission-in-pla2r-antibody-associated-membranous-nephropathy/)
- [Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up](https://scholariq.org/papers/serum-anti-pla2r-antibodies-can-be-initially-absent-in-idiopathic-membranous/)
- [The bias between different albumin assays may affect clinical decision-making](https://scholariq.org/papers/the-bias-between-different-albumin-assays-may-affect-clinical-decision-making/)
- [Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice](https://scholariq.org/papers/interleukin-6-is-essential-for-glomerular-immunoglobulin-a-deposition-and-the/)
- [HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients](https://scholariq.org/papers/hla-d-and-pla2r1-risk-alleles-associate-with-recurrent-primary-membranous/)
- [Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy](https://scholariq.org/papers/anti-pla2r1-antibodies-as-prognostic-biomarker-in-membranous-nephropathy/)
- [Pharmacological treatment of primary membranous nephropathy in 2016](https://scholariq.org/papers/pharmacological-treatment-of-primary-membranous-nephropathy-in-2016/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)

## Researcher university

- [Radboud University Nijmegen](https://scholariq.org/institutions/radboud-university-nijmegen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.